Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Union Agener operates a state-of-the-art, FDA-certified biotechnology facility in Augusta, Georgia. Its flagship product is recombinant bovine somatotropin (rbST), marketed as Posilac® and Lactotropin®, which is used to increase milk yield in dairy cows. The company was acquired by União Química in 2018 and has since expanded its global reach through partnerships such as the exclusive worldwide distributorship agreement with MSD Animal Health for LACTOTROPIN® outside select markets[3][5]. Clinical results demonstrate increased efficiency and productivity for dairy producers using their products[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Union Agener.